U.S. Stock Market Midday Update

ENDRA Life Sciences rose 210.71%. Based on recent important news:

1. On June 9, innovative drug concept stocks performed strongly, with an average price increase of 27.34% year-to-date, among which several stocks doubled in price, driving ENDRA Life Sciences' stock price significantly higher.

2. On May 22, the company announced a buyback plan to enhance investor confidence, leading to a rise in stock price.

3. On July 8, a report from Galaxy Securities pointed out that a turning point in the life sciences industry has emerged, with industry leaders accelerating expansion, driving stock prices up.

Stocks with High Trading Volume in the Industry

Intuitive Surgical fell 0.20%, with a trading volume of $11.22 million. Based on recent important news:

1. On July 5, Intuitive Surgical launched the fifth-generation da Vinci system and began integrating AI features. Despite increased competition, the future outlook remains optimistic, and the stock price retains long-term investment value.

2. On July 5, market confidence in long-term investment returns increased, stabilizing the stock price.

3. On July 8, Citigroup analysts are optimistic about the AI market outlook. Although primarily focused on Nvidia, this has a positive impact on overall tech stocks.

Biosig Tech rose 9.52%, with a trading volume of $10.69 million. Based on recent important news:

1. On January 19, Innovent Biologics' stock price fell over 10% following news of centralized procurement in the Anhui biopharmaceutical alliance, affecting innovative drug companies' stock prices.

2. On January 20, Morgan Stanley believed that the privatization event of Fosun Pharma had limited impact on the company.

3. On January 13, WuXi AppTec signed a licensing agreement with Abbott, driving the stock price up.

Abbott fell 0.53%, with a trading volume of $8.93 million. Based on recent important news:

1. On July 8, market analysts did not include Abbott in their recommended list, leading to a decline in investor confidence and a 0.53% drop in stock price.

2. On July 6, Abbott's FreeStyle Libre device achieved historic sales success, but market concerns about the white space affected the stock price.

3. On July 6, the growth potential of Abbott's structural heart products was emphasized, which is beneficial in the long term but has limited short-term impact.

Stocks with High Market Capitalization in the Industry

Abbott fell 0.53%, with a market capitalization of $231.5 billion. Based on recent important news:

1. On July 6, Abbott's FreeStyle Libre became the most successful medical device in history, driving long-term growth. The stock price remained stable.

2. On July 8, analysts did not include Abbott in their recommended list, affecting market confidence and leading to a decline in stock price.

3. On July 7, the market maintained confidence in Abbott's innovation capabilities and dividend growth, resulting in limited stock price fluctuations